Nintedanib in progressive bronchiolitis obliterans syndrome (BOS) grade 0p-1-2 in lung transplant recipients (INFINITIx-BOS): protocol of a French multicenter randomized controlled trial. - Brugière O; Hirschi S; Reynaud-Gaubert M; Bunel V; Demant X; Le Pavec J; Falque L; Si Mohammed N; Tardivon C; Couffignal C (Trials, 2026)